{"id":"W4405584069","doi":"10.1002/ajh.27563","title":"Treatment Effectiveness of Venetoclax‐Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real‐World Study","year":2024,"lang":"en","type":"letter","venue":"American Journal of Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Incyte; Pharmacyclics; Genentech; Grifols; Galápagos; MEI Pharma; BeiGene; National Cancer Institute; AbbVie; Seagen; Gilead Sciences; Loxo Oncology; TG Therapeutics; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Venetoclax; Medicine; Chronic lymphocytic leukemia; Discontinuation; Ibrutinib; Internal medicine; Oncology; Clinical trial; Idelalisib; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007805037,0.0006219158,0.002565892,0.00217857,0.00002488768,0.00003126279,0.0005079715,0.0003445989,0.0001237042],"category_scores_gemma":[0.00008216006,0.0004671002,0.0004990214,0.0009323806,0.0007390155,0.0001234667,0.00009149288,0.001502017,0.00001947664],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.2063626,"about_ca_system_score_gemma":0.0677271,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00880258,"about_ca_topic_score_gemma":0.0004551671,"domain_scores_codex":[0.9949332,0.001163776,0.001497902,0.0006836691,0.001052185,0.0006692231],"domain_scores_gemma":[0.9965696,0.001073924,0.0009637075,0.0008015246,0.0003926525,0.0001985385],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.09354831,0.005018436,0.1024501,0.01035601,0.01625661,0.6425129,0.00510343,0.008864854,0.006987458,0.0001236672,0.02636759,0.0824107],"study_design_scores_gemma":[0.3671515,0.2422808,0.04087737,0.02900144,0.005085524,0.05032326,0.00179898,0.03155136,0.08037864,0.0003528631,0.1471234,0.004074899],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896286,0.002200624,0.00001164355,0.005751392,0.0008489492,0.001296465,0.00002664782,0.00002990152,0.000205832],"genre_scores_gemma":[0.9923728,0.0008752486,0.0000912777,0.004562831,0.001535653,0.0001950365,0.00007837495,0.0001557018,0.0001330819],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5921896,"threshold_uncertainty_score":0.9997781,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0186158064601441,"score_gpt":0.3424328678919236,"score_spread":0.3238170614317795,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}